Identifying Tyrosine Kinase Inhibitor Nonadherence in Chronic Myeloid Leukemia: Subanalysis of TAKE-IT Pilot Study
Authors:
- Avi LeaderALAvi Leader
- Anat Gafter-GviliAGAnat Gafter-Gvili
- Noam BenyaminiNBNoam Benyamini
- Juliet DreyerJDJuliet Dreyer
- Bronya CalvaryskyBCBronya Calvarysky
- Alina AmitaiAAAlina Amitai
- Osnat Yarchovsky-DolbergOYOsnat Yarchovsky-Dolberg
- Giora SharfGSGiora Sharf
- Eric ToussetETEric Tousset
- Opher CaspiOCOpher Caspi
- Martin EllisMEMartin Ellis
- Itai LeviILItai Levi
- 1 September 2018
- journal article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 18 (9) , e351-e362
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Effect of Adherence-enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): A Quasi-experimental Pre–Post Intervention Multicenter Pilot StudyClinical Lymphoma Myeloma and Leukemia, 2018
- Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitorsMedical Oncology, 2017
- Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countriesJournal of Cancer Research and Clinical Oncology, 2017
- Comprehensive Evaluation of Adherence to Therapy, Its Associations, and Its Implications in Patients With Chronic Myeloid Leukemia Receiving ImatinibClinical Lymphoma Myeloma and Leukemia, 2016
- To adhere or not to adhere: Rates and reasons of medication adherence in hematological cancer patientsCritical Reviews in Oncology/Hematology, 2016
- Preliminary Validation of Self‐assessment Tool to Measure Imatinib Adherence in Patients with Chronic Myeloid LeukemiaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVECHematological Oncology, 2012
- Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational studyAnnals of Hematology, 2011
- Exploring chronic myeloid leukemia patients’ reasons for not adhering to the oral anticancer drug imatinib as prescribedLeukemia Research, 2011
- Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemiaAmerican Journal of Hematology, 2011